Galectin-3 mediates cross-talk between K-ras and let-7c tumor suppressor microRNA

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Levy, Ran ^a   Biran, Anat ^a   Poirier, Francoise ^b   Raz, Avraham ^c   Kloog, Yoel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUT JACQUES MONOD   (France)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE I; GALECTIN 1; GALECTIN 3; K RAS PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; BIOLOGICAL MARKER; KRAS2 PROTEIN, MOUSE; LGALS3 PROTEIN, MOUSE; MESSENGER RNA; MIRNLET7 MICRORNA, MOUSE; PROTEIN P21;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME INHIBITION; FIBROBLAST; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WILD TYPE; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL MOTION; CELL NUCLEUS; CELL PROLIFERATION; CYTOLOGY; CYTOPLASM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASEIN KINASE I; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CYTOPLASM; EMBRYO, MAMMALIAN; FIBROBLASTS; GALECTIN 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 81055144862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027490     Document Type: Article

References (42)

1. He L, Hannon GJ, (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
2. Shenouda SK, Alahari SK, (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28: 369-378.
3. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
4. Akao Y, Nakagawa Y, Naoe T, (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906.
5. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 64: 3753-3756.
6. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M, (2008) MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res 18: 549-557.
7. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
8. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proceedings of the National Academy of Sciences of the United States of America 105: 3903-3908.
9. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Research 68: 8535-8540.
10. Shalom-Feuerstein R, Cooks T, Raz A, Kloog Y, (2005) Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells. Cancer Res 65: 7292-7300.
11. Elad-Sfadia G, Haklai R, Balan E, Kloog Y, (2004) Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 279: 34922-34930.
12. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, et al. (1994) Galectins: a family of animal beta-galactoside-binding lectins. Cell 76: 597-598.
13. Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M, (1994) Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. International Journal of Cancer 58: 185-191.
14. Bos JL, (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689.
15. Cox AD, Der CJ, (2003) The dark side of Ras: regulation of apoptosis. Oncogene 22: 8999-9006.
16. Downward J, (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11-22.
17. Mitin N, Rossman KL, Der CJ, (2005) Signaling interplay in Ras superfamily function. Curr Biol 15: R563-574.
18. Shalom-Feuerstein R, Plowman SJ, Rotblat B, Ariotti N, Tian T, et al. (2008) K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3. Cancer Res 68: 6608-6616.
19. Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y, (2010) Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas. Mol Cancer Ther 9: 2208-2219.
20. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, et al. (2004) Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24: 4395-4406.
21. Huflejt ME, Turck CW, Lindstedt R, Barondes SH, Leffler H, (1993) L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I.J Biol Chem 268: 26712-26718.
22. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS, (2000) Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275: 36311-36315.
23. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, et al. (2007) Let-7 expression defines two differentiation stages of cancer. Proceedings of the National Academy of Sciences of the United States of America 104: 11400-11405.
24. Poirier F, Robertson EJ, (1993) Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 119: 1229-1236.
25. Colnot C, Fowlis D, Ripoche MA, Bouchaert I, Poirier F, (1998) Embryonic implantation in galectin 1/galectin 3 double mutant mice. Dev Dyn 211: 306-313.
26. Colnot C, Ripoche MA, Scaerou F, Foulis D, Poirier F, (1996) Galectins in mouse embryogenesis. Biochem Soc Trans 24: 141-146.
27. Shapira S, Barkan B, Fridman E, Kloog Y, Stein R, (2006) The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways. Cell Death Differ.
28. Niv H, Gutman O, Henis YI, Kloog Y, (1999) Membrane interactions of a constitutively active GFP-K-Ras 4B and their role in signaling: Evidence from lateral mobility studies. J Biol Chem 274: 1606-1613.
29. Niv H, Gutman O, Kloog Y, Henis YI, (2002) Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells. J Cell Biol 157: 865-872.
30. Elad-Sfadia G, Haklai R, Ballan E, Gabius HJ, Kloog Y, (2002) Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J Biol Chem 277: 37169-37175.
31. Rena G, Bain J, Elliott M, Cohen P, (2004) D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep 5: 60-65.
32. Mazurek N, Conklin J, Raz A, Byrd JC, Bresalier RS, (2000) Phosphorylation of the {beta}-galactoside binding protein galectin-3 modulates binding to its ligands. J Biol Chem.
33. Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, et al. (2002) Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277: 6852-6857.
34. Rosseland CM, Wierod L, Flinder LI, Oksvold MP, Skarpen E, et al. (2008) Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K. Journal of Cellular Physiology 215: 818-826.
35. Nakahara S, Raz A, (2006) On the role of galectins in signal transduction. Methods Enzymol 417: 273-289.
36. Nelson HH, Christensen BC, Plaza SL, Wiencke JK, Marsit CJ, et al. (2010) KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. Lung Cancer 69: 51-53.
37. Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, et al. (2009) A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers. Carcinogenesis 30: 1003-1007.
38. Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, et al. (2010) Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J 10: 458-464.
39. Zhang H, Li Y, Lai M, (2009) The microRNA network and tumor metastasis. Oncogene 29: 937-948.
40. Philips MR, (2005) Compartmentalized signalling of Ras. Biochem Soc Trans 33: 657-661.
41. Cox AD, Garcia AM, Westwick JK, Kowalczyk JJ, Lewis MD, et al. (1994) The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation. J Biol Chem 269: 19203-19206.
42. Der CJ, Van Dyke T, (2007) Stopping ras in its tracks. Cell 129: 855-857.